Pivekimab Sunirine
Near Add Your Location
Accepting patients
PVEK (IMGN632)
Phase 1 Study of FLAG-Ida With Pivekimab Sunirine (PVEK [IMGN632]) for Adults With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
- Antibody Drug Conjugate (ADC)
- CD123
- Phase 1
Showing 1-1 of 1